InsiderTrades

Form 4 for MAS Masco

Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-04 · accession 0001225208-24-009676 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-11-06 2024-11-04 MAS Straber Renee VP - Chief HR Off S - Sale+OE $80.54 -42.1K 33.9K -55% -$3.39M
DM 2024-11-06 2024-11-04 MAS Straber Renee VP - Chief HR Off M - OptEx $45.09 +42.1K 57.0K +284% +$1.90M
DM 2024-11-06 2024-11-04 MAS Straber Renee VP - Chief HR Off M - OptEx — -42.1K 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-11-04 S D 42,150 $80.54 33,864 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.44 to $80.63, inclusive. The reporting person undertakes to provide to Masco Corporation, any security holder of Masco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
2 Common Common Stock 2024-11-04 M A 19,020 $42.13 76,014 D — —
3 Common Common Stock 2024-11-04 M A 23,130 $47.53 56,994 D — —
4 Derivative Employee Stock Option 2024-11-04 M D 23,130 — 0 D $47.53 · — to 2030-02-11 23,130 Common Stock (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F4) This option became exercisable in three approximately equal annual installments commencing February 11, 2021.
5 Derivative Employee Stock Option 2024-11-04 M D 19,020 — 0 D $42.13 · — to 2028-02-09 19,020 Common Stock (F3) Grant of option under the Masco Corporation 2014 Long Term Stock Incentive Plan in transactions exempt under Rule 16b-3. (F2) This option became exercisable in five equal annual installments commencing February 9, 2019.